GS vs UNH: Which Is the Better Buy?
Side-by-side comparison of The Goldman Sachs Group, Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-29.
The Goldman Sachs Group, Inc. · Financial Services
$926.55
-45.0% upside to fair value
Grade D
VS
UnitedHealth Group Incorporated · Healthcare
$353.52
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
UNH has more upside to fair value
(+45.0%).
GS trades at a lower forward P/E
(15.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GS |
UNH |
| Current Price |
$926.55 |
$353.52 |
| Fair Value Estimate |
$509.60 |
$512.60 |
| Upside to Fair Value |
-45.0%
|
+45.0%
|
| Market Cap |
$275.0B |
$320.9B |
| Forward P/E |
15.6x
|
26.7x
|
| EV / EBITDA |
30.6x
|
16.1x
|
| Price / Sales |
2.5x
|
0.7x
|
| Price / FCF |
-5.8x
|
16.3x
|
| Revenue Growth YoY |
-45.4%
|
+2.0%
|
| Gross Margin |
55.5%
|
18.8%
|
| Operating Margin |
20.5%
|
4.2%
|
| Return on Equity |
14.6%
|
12.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
6.13%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
The Goldman Sachs Group, Inc. operates as a leading global financial services firm specializing in investment banking, securities, investment management, and consumer banking. The company benefits from a high-quality business model characterized by strong brand recognition, deep client relationships, and a history of stable leadership. However, the stock is currently significantly overvalued, tra…
UnitedHealth Group Incorporated operates as a leading healthcare company with two main platforms: UnitedHealthcare, providing health benefits coverage, and Optum, offering information and technology services. The company benefits from a durable competitive moat due to its scale, integrated platforms, and broad market reach serving over 170 million consumers. Despite strong revenue growth of 12% y…
Accumulation Zones
| Metric |
GS |
UNH |
| Zone Low |
$382.20 |
$384.45 |
| Zone High |
$433.16 |
$435.71 |
| In Buy Zone? |
No
|
Yes
|